Executioner CASP3, commonly used as a marker for the efficacy of cancer treatment, is involved in modulating colon cancer cell survival, proliferation, apoptosis, migration, invasion, and metastasis [90,91]. This evidence concerns the gene CASP3 and colonic neoplasm.